Fault Tolerant Strategies for Automated Insulin Delivery Considering the Human Component: Current and Future Perspectives

Abstract

Automated Insulin Delivery (AID) are systems developed for daily use by people with type 1 diabetes (T1D). To ensure the safety of users, it is essential to consider how the human factor affects the performance and safety of these devices. While there are numerous publications on hardware-related failures of AID systems, there are few studies on the human component of the system. From a control point of view, people with T1D using AID systems are at the same time the plant to be controlled and the plant operator. Therefore, users may induce faults in the controller, sensors, actuators, and the plant itself. Strategies to cope with the human interaction in AID systems are needed for further development of the technology. In this paper, we present an analysis of potential faults introduced by AID users when the system is under normal operation. This is followed by a review of current fault tolerant control (FTC) approaches to identify missing areas of research. The paper concludes with a discussion on future directions for the new generation of FTC AID systems.

Application of Artificial Intelligence in Discovery and Development of Anticancer and Antidiabetic Therapeutic Agents

“…Meal data are crucial context information. It demonstrated that subjective trend analysis utilizing CGM can provide accurate meal timing and ground truth [ 166 ]. Similarly, in order to increase glucose prediction accuracy, ML algorithms were applied to detect daily food and physical activity patterns in [ 167 ].…”

A Hybrid Automata Approach for Monitoring the Patient in the Loop in Artificial Pancreas Systems

“…The observer gain can be designed by solving the associated LQC dual problem [47]. Given the system description (26), tuning matrices Q = Q T = H T H ≥ 0, R = R T > 0 and the performance bound γ. Then, the observer gains for the polytopic system are obtained by finding Υ and W i through the solution of the following LMI minimization problem min γ,Υ=Υ T ,W γ (30) subject to…”

“…The aim of this work is to provide robust and safe solutions to deal with the patientin-the-loop in AP systems. In the context of diabetes and AP systems, the patient should be considered as part of the control loop [26]. Depending on the system configuration, the patient may have to take the role of an actuator or a sensor, besides being the plant to control.…”